CHARLOTTE – Durham-based biopharmaceutical Chimerix has promoted Michelle LaSpaluto, current vice president of corporate financial planning and investor relations, to chief financial officer effective December 1.
Prior to joining Chimerix, LaSpaluto was Senior Director of Accounting at AlphaVax.
She holds an MBA from East Carolina University and a BA in accounting from Michigan State University.